Intensity-Modulated Radiation Therapy Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma Interventions: Drug: Gemcitabine,Cisplatin; Radiation: Intensity-modulated radiation therapy (IMRT); Drug: Cisplatin Sponsors: Wei Jiang; Wuzhou Red Cross Hospital; Guangxi Zhuang Autonomous Region People's Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 2, 2022 Category: Research Source Type: clinical trials
